Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 45(10): 982-987, Oct. 2012. ilus, tab
Artigo em Inglês | LILACS | ID: lil-647755

RESUMO

The periaqueductal gray (PAG) has been reported to be a location for opioid regulation of pain and a potential site for behavioral selection in females. Opioid-mediated behavioral and physiological responses differ according to the activity of opioid receptor subtypes. The present study investigated the effects of the peripheral injection of the kappa-opioid receptor agonist U69593 into the dorsal subcutaneous region of animals on maternal behavior and on Oprk1 gene activity in the PAG of female rats. Female Wistar rats weighing 200-250 g at the beginning of the study were randomly divided into 2 groups for maternal behavior and gene expression experiments. On day 5, pups were removed at 7:00 am and placed in another home cage that was distant from their mother. Thirty minutes after removing the pups, the dams were treated with U69593 (0.15 mg/kg, sc) or 0.9% saline (up to 1 mL/kg) and after 30 min were evaluated in the maternal behavior test. Latencies in seconds for pup retrieval, grouping, crouching, and full maternal behavior were scored. The results showed that U69593 administration inhibited maternal behavior (P < 0.05) because a lower percentage of kappa group dams showed retrieval of first pup, retrieving all pups, grouping, crouching and displaying full maternal behavior compared to the saline group. Opioid gene expression was evaluated using real-time reverse-transcription polymerase chain reaction (RT-PCR). A single injection of U69593 increased Oprk1 PAG expression in both virgin (P < 0.05) and lactating female rats (P < 0.01), with no significant effect on Oprm1 or Oprd1 gene activity. Thus, the expression of kappa-opioid receptors in the PAG may be modulated by single opioid receptor stimulation and behavioral meaningful opioidergic transmission in the adult female might occur simultaneously to specific changes in gene expression of kappa-opioid receptor subtype. This is yet another alert for the complex role of the opioid ...


Assuntos
Animais , Feminino , Ratos , Comportamento Animal/fisiologia , Lactação/fisiologia , Comportamento Materno/fisiologia , Substância Cinzenta Periaquedutal/efeitos dos fármacos , Receptores Opioides kappa/agonistas , Comportamento Animal/efeitos dos fármacos , Expressão Gênica , Lactação/efeitos dos fármacos , Lactação/genética , Comportamento Materno/efeitos dos fármacos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Receptores Opioides kappa/genética
2.
Braz. j. med. biol. res ; 31(2): 225-30, feb. 1998. ilus, tab
Artigo em Inglês | LILACS | ID: lil-212572

RESUMO

The nucleus tractus solitarii (NTS) in the dorsomedial medulla comprises a wide range of neuropeptides and biogenic amines. Several of them are related to mechanism of central blood pressure control. Angiotensin II (Ang II), neuropeptide Y (NPY) and noradrenaline (NA) are found in the NTS cells, as well as their receptors. Based on this observation we have evaluated the modulatory effect of these peptide receptors on alpha2-adrenoceptors in the NTS. Using quantitative recptor radioautography, we observed that NPY and Ang II receptors decreased the affinity of alpha1-adrenoceptors for their agonists in the NTS of the rat. Cardiovascular experiments agreed with the in vitro data. Coinjection of a threshold dose of Ang II of the NPY agonists together with an ED50 dose of adrenergic agonists such as NA, adrenaline and clonidine counteracted the depressor effect produced by the alpha2-agonist in the NTS. The results provide evidence for the existence of an antagonistic interaction between Ang II AT1 receptors and NPY receptor subtypes with the alpha2-adrenoceptors in the NTS. This receptor interaction may reduce the transduction over the alpha2-adrenoceptors which can be important in central cardiovascular regulation and in the development of hypertension.


Assuntos
Ratos , Animais , Angiotensina II/farmacologia , Pressão Sanguínea/fisiologia , Clonidina/farmacologia , Epinefrina/farmacologia , Técnicas In Vitro , Neuropeptídeo Y , Norepinefrina/farmacologia , Receptores Adrenérgicos/fisiologia , Receptores de Angiotensina/fisiologia , Receptores de Neuropeptídeo Y/fisiologia , Núcleo Solitário/química , Autorradiografia , Hipertensão/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA